DJIA 18,087.04 -116.33 -0.64%
NASDAQ 4,968.56 -11.34 -0.23%
S&P 500 2,098.76 -9.02 -0.43%
market minute promo

TESARO (NASDAQ: TSRO)

51.44 -0.93 (-1.78%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

TSRO $51.44 -1.78%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $51.27
Previous Close $52.37
Daily Range $50.58 - $52.35
52-Week Range $22.15 - $54.72
Market Cap $1.9B
P/E Ratio -10.93
Dividend (Yield) $0.00 (0.0%)
Volume 1,844,558
Average Daily Volume 411,175
Current FY EPS -$5.10

Sector

Healthcare

Industry

Drug Makers

TESARO (TSRO) Description

TESARO Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients. Website: http://www.tesarobio.com/

News & Commentary

3 Biotech Stocks That Are Soaring Higher

These three biotech stocks have recently jumped by more than 25%

Benzinga's Top #PreMarket Losers

Jeff Cooper: How Big Is The Next Trend Turn?

If the market melts up from here, the cycles suggest a possible melt-down.

TESARO (TSRO) is in Overbought Territory: What's Next? - Tale of the Tape

Citigroup Adds Tesaro To 'Focus List,' Removes Medivation

TESARO's (TSRO) CEO Lonnie Moulder on Q4 2014 Results - Earnings Call Transcript

Investing In Precision Oncology: Targeting NTRK Genomic Alterations

Insiders Were Right: TSRO Makes New 52-Week High

Interesting TSRO Put And Call Options For February 20th

TSRO: Insiders Vs. Shorts

See More TSRO News...